Raumedic has appointed Stefan Seuferling to its executive board to help strengthen the company’s management team. He will be responsible for leading the business operations of the Helmbrechts-based medtech manufacturer.
Seuferling will oversee the strategic and operative positioning of sales activities of the company in Europe and Asia. The company says he will also be responsible for the marketing communication, quality management and regulatory affairs departments as well.
“We would like to extend a warm welcome to Mr. Seuferling as a new member on the executive board of Raumedic AG. By hiring him, we have added a strong executive to the board in order to better position our company in European and Asian markets. Mr. Seuferling will naturally receive support from the entire executive board in his work to achieve this goal,” Martin Bayer, Raumedic’s CEO, said in a press release.
Prior to joining Raumedic, Seuferling was responsible for overseeing the global development organization of a medtech company in northern Germany. He was also responsible for entire sales operations in Europe and was a management team member at a medical implant company.
“Raumedic is a rapidly growing company with tremendous potential. I want to help fuel the company’s continued growth and further expand our market presence,” Seuferling said. “It’s also nice that my commute to work is much shorter.”
